Electromed, Inc. (ELMD): Price and Financial Metrics


Electromed, Inc. (ELMD): $11.50

0.05 (+0.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ELMD Stock Summary

  • The price/operating cash flow metric for Electromed Inc is higher than 93.19% of stocks in our set with a positive cash flow.
  • The ratio of debt to operating expenses for Electromed Inc is higher than it is for about merely 0.5% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.14 for Electromed Inc; that's greater than it is for only 10.32% of US stocks.
  • Stocks that are quantitatively similar to ELMD, based on their financial statements, market capitalization, and price volatility, are PESI, SWBI, KAI, HAPP, and CCF.
  • Visit ELMD's SEC page to see the company's official filings. To visit the company's web site, go to www.smartvest.com.

ELMD Valuation Summary

  • In comparison to the median Healthcare stock, ELMD's price/earnings ratio is 23.29% higher, now standing at 45.
  • Over the past 135 months, ELMD's price/sales ratio has gone up 0.7.
  • Over the past 135 months, ELMD's price/sales ratio has gone up 0.7.

Below are key valuation metrics over time for ELMD.

Stock Date P/S P/B P/E EV/EBIT
ELMD 2021-08-31 3.0 3.3 45.0 29.8
ELMD 2021-08-30 3.0 3.3 44.7 29.6
ELMD 2021-08-27 2.8 3.1 42.7 28.1
ELMD 2021-08-26 2.8 3.1 43.0 28.3
ELMD 2021-08-25 2.8 3.1 41.9 27.5
ELMD 2021-08-24 2.9 3.2 44.0 29.0

ELMD Growth Metrics

    Its 2 year cash and equivalents growth rate is now at 40.64%.
  • Its 4 year price growth rate is now at 244.49%.
  • Its 3 year net income to common stockholders growth rate is now at -6.05%.
ELMD's revenue has moved up $7,568,042 over the prior 34 months.

The table below shows ELMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 38.50476 1.480121 1.900311
2021-09-30 37.75283 1.67905 2.265738
2021-06-30 35.756 3.077 2.362
2021-03-31 33.16457 3.608987 3.271013
2020-12-31 33.12149 3.663728 3.700516
2020-09-30 32.17236 4.389356 3.682145

ELMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ELMD has a Quality Grade of A, ranking ahead of 95.51% of graded US stocks.
  • ELMD's asset turnover comes in at 0.99 -- ranking 21st of 183 Medical Equipment stocks.
  • DYNT, SYK, and IRMD are the stocks whose asset turnover ratios are most correlated with ELMD.

The table below shows ELMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.990 0.764 0.161
2021-03-31 0.943 0.783 0.196
2020-12-31 0.971 0.781 0.234
2020-09-30 0.974 0.777 0.239
2020-06-30 1.015 0.776 0.279
2020-03-31 1.102 0.768 0.301

ELMD Stock Price Chart Interactive Chart >

Price chart for ELMD

ELMD Price/Volume Stats

Current price $11.50 52-week high $13.85
Prev. close $11.45 52-week low $9.52
Day low $11.46 Volume 3,600
Day high $11.75 Avg. volume 11,060
50-day MA $12.45 Dividend yield N/A
200-day MA $12.20 Market Cap 98.13M

Electromed, Inc. (ELMD) Company Bio


Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.


ELMD Latest News Stream


Event/Time News Detail
Loading, please wait...

ELMD Latest Social Stream


Loading social stream, please wait...

View Full ELMD Social Stream

Latest ELMD News From Around the Web

Below are the latest news stories about Electromed Inc that investors may wish to consider to help them evaluate ELMD as an investment opportunity.

Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer

NEW PRAGUE, Minn., February 16, 2022--Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer

Yahoo | February 16, 2022

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Electromed (ELMD) and Pfizer (PFE)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN – Research Report), Electromed (ELMD – Research Report) and Pfizer (PFE – Research Report). Amgen (AMGN) Jefferies analyst Michael Yee maintained a Buy rating on Amgen yesterday and set a price target of $266.00. The company's shares closed last Monday at $223.53. According to TipRanks.

Brian Anderson on TipRanks | February 8, 2022

Electromed, Inc. (ELMD) CEO Kathleen Skarvan On Q2 2022 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 8, 2022

Electromed, Inc. Announces Second Quarter Financial Results

NEW PRAGUE, Minn., February 08, 2022--Electromed, Inc. Announces Second Quarter Financial Results

Yahoo | February 8, 2022

Electromed, Inc. Schedules its Second Quarter Fiscal 2022 Financial Results Conference Call for February 8, 2022 at 5:00 p.m. ET

NEW PRAGUE, Minn., January 27, 2022--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 second quarter ended December 31, 2021, on Tuesday, February 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.

Yahoo | January 27, 2022

Read More 'ELMD' Stories Here

ELMD Price Returns

1-mo N/A
3-mo -5.70%
6-mo -4.33%
1-year 16.63%
3-year 130.46%
5-year 161.96%
YTD -11.54%
2021 32.52%
2020 13.41%
2019 69.94%
2018 -16.14%
2017 56.44%

Continue Researching ELMD

Want to see what other sources are saying about Electromed Inc's financials and stock price? Try the links below:

Electromed Inc (ELMD) Stock Price | Nasdaq
Electromed Inc (ELMD) Stock Quote, History and News - Yahoo Finance
Electromed Inc (ELMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6119 seconds.